
Proposed Placing of new ordinary shares to raise at least £1.5 million
NetScientific PLC, the life sciences and sustainability technology investment and commercialisation group, is pleased to announce that the Company is carrying out an equity fundraising to raise at least £1.5 million (the “Placing”), before expenses, via the issue of an …

Q-Bot Limited (“Q-Bot”) secures £1.6m of investment to fund growth
NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group announces that portfolio company Q-Bot has successfully closed a £1.62m investment round to fund the next stage of its growth. The additional funds will allow …

PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101
NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has been granted Fast Track designation for PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® …

Foxberry expands in Australia with Foxf9 developed BetaShares ETF
London, 2 June 2022 Foxberry Ltd, the provider of financial indices and front-office technology for the financial sector, today announced that BetaShares in Australia has chosen Foxberry as the index provider for its new Future of Food ETF investing in the …

PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza Vaccine
London, UK – 28 January 2022 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS”), announced yesterday preclinical data for its universal flu vaccine, …

Q-Bot Investment and Share Acquisition – NetScientific Plc
Q-Bot Investment and Share Acquisition NetScientific takes c.19% direct stake in construction industry robotics company Q-Bot and leads Convertible Loan round London, UK – 21 December 2021 – NetScientific plc (AIM:NSCI), the international life sciences and sustainability technology investment and commercialisation Group, …

EMVC syndicates additional £0.73m investment
Syndication highlights strength of capital light investment model London, UK – 13 December 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that on 9 December 2021 its corporate finance and venture …

PDS Phase 2 Clinical Trial Update
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination London, UK – 06 December 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio …

Sofant Signs €7.3m European Space Agency Contract
London, UK – 4 November 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, Sofant Technologies ("Sofant"), the leading 5G and Satcom antenna developer based in Edinburgh, has …

EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer Sofant Technologies
London, UK – 26 October 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its corporate finance and venture capital division EMV Capital Ltd ("EMVC") advised on a £843k fundraise, made …